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ABSTRACT
CONTEXT AND OBJECTIVE: The combined effect of obesity and asthma may lead to significant im-
pairment of quality of life (QOL). The aim here was to evaluate the prevalence of asthma among obese 
individuals, characterize the severity of impairment of quality of life and measure its relationship with 
pulmonary function. 
DESIGN AND SETTING: Observational cross-sectional study in public university hospital.
METHODS: Morbidly obese individuals (body mass index > 40 kg/m2) seen in a bariatric surgery outpa-
tient clinic and diagnosed with asthma, were included. Anthropometric data were collected, the Stan-
dardized Asthma Quality of Life Questionnaire (AQLQ(S)) was applied and spirometry was performed. The 
subjects were divided into two groups based on the median of the score in the questionnaire (worse < 4 
and better ≥ 4) and were compared regarding anthropometric data and pulmonary function. 
RESULTS: Among the 4791 individuals evaluated, 219 were asthmatic; the prevalence of asthma was 
4.57%. Of these, 91 individuals were called to start multidisciplinary follow-up during the study period, 
of whom 82 answered the questionnaire. The median score in the AQLQ(S) was 3.96 points and, thus, the 
individuals were classified as having moderate impairment of their overall QOL. When divided according 
to better or worse QOL, there was a statistically difference in forced expiratory flow (FEF) 25-75%, with 
higher values in the better QOL group. 
CONCLUSION: The prevalence of asthma was 4.57% and QOL was impaired among the asthmatic obese 
individuals. The worst QOL domain related to environmental stimuli and the best QOL domain to limita-
tions of the activities. Worse QOL was correlated with poorer values for FEF 25-75%. 
RESUMO
CONTEXTO E OBJETIVO: O efeito combinado de obesidade e asma pode levar a um comprometimento 
significativo da qualidade de vida (QV). O objetivo foi avaliar a prevalência de asma entre obesos, caracte-
rizar a gravidade do comprometimento da QV e verificar sua relação com a função pulmonar.  
TIPO DE ESTUDO E LOCAL: Estudo transversal observacional em hospital universitário público.
MÉTODOS: Foram incluídos indivíduos obesos mórbidos (indice de massa corporal > 40 kg/m2), acom-
panhados num ambulatório de cirurgia bariátrica e diagnosticados com asma. Foram coletados dados 
antropométricos e aplicado o Standardized Asthma Quality of Life Questionnaire (AQLQ (S)), bem como 
a espirometria. Os indivíduos foram divididos em dois grupos com base na mediana obtida no escore 
do questionário (pior < 4 e melhor ≥ 4) e os grupos foram comparados aos dados antropométricos e 
função pulmonar. 
RESULTADOS: Dos 4.791 indivíduos avaliados, 219 eram asmáticos; a prevalência de asma foi de 4,57%. 
Destes, 91 indivíduos foram chamados para iniciar o acompanhamento multidisciplinar no período do 
estudo, sendo que 82 responderam ao questionário. A pontuação mediana do AQLQ (S) foi de 3,96 pon-
tos, portanto, classificados com prejuízo moderado na QV global. Quando divididos por melhor ou pior 
QV, houve diferença estatística no fluxo expiratório forçado (FEF) 25-75%, com maior valor no grupo 
com melhor QV.
CONCLUSÃO: A prevalência da asma na população estudada foi de 4,57% e há prejuízos na QV de obesos 
asmáticos, sendo o pior domínio de QV relacionado aos estímulos ambientais e o melhor domínio de QV 
relacionado às limitações das atividades. A pior QV se relacionou a piores valores de FEF 25-75%.
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Testes de função respiratória.
Espirometria.
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INTRODUCTION
Asthma is a chronic inflammatory disease of the airways that is 
associated with hyper-responsivity. It leads to recurrent episodes of 
wheezing, dyspnea, sensation of chest tightness and coughing, par-
ticularly at night or in the early morning. The obstruction to the 
airflow may be reversed spontaneously or by means of treatment. 
About 300 million individuals worldwide present asthma. The fac-
tors associated with the disease include environmental factors relat-
ing to allergies, occupation, smoking, infections, pollution and diet; 
and endogenous factors relating to genetics, gender and obesity.1
Asthma is diagnosed based on the symptoms and is confirmed 
through pulmonary function tests, such as spirometry and expira-
tory flow peak measurement. These enable evaluation of the severity 
of the limitation to the airflow and its reversibility and variability.1
In a meta-analysis by Beuther et al.,2 it was observed that obese indi-
viduals were more likely to develop asthma than were lean individuals. 
The exact mechanism for development of asthma is uncertain, but the 
inflammation mediators produced by the adipose tissue may contribute 
towards a low-grade systemic inflammatory state and promote changes 
to pulmonary function, thus leading to episodes of bronchospasm.
Today, obesity has reached epidemic levels and has become a 
public health concern. In 2014, more than 1.9 billion adult indi-
viduals (39%) were at least overweight, and of these, more than 
600 million were obese.3 Obesity is defined as body mass index 
(BMI) greater than or equal to 30 kg/m2 and considered to be a 
multifactorial disease.4 Its probable causes are a combination of 
genetic, endocrine, behavioral, socioeconomic, psychological and 
environmental imbalances, and it  leads to several comorbidities.5
Follow-up for asthmatic patients is necessary, with the aims of 
controlling the condition and avoiding exacerbations and the need 
for in-hospital assistance, especially when it is associated with obesity. 
Assessment of this information by means of questionnaires is use-
ful within clinical practice and scientific research, since this allows 
standardization and reproducibility of measurements at low cost.
OBJECTIVE
The aims of this study were to evaluate the prevalence of asthma 
in the obese population, characterize its severity of impairment 
of the quality of life of asthmatic obese individuals and measure 
its influence on pulmonary function.
METHODS
Study design and setting
This was an observational cross-sectional study conducted at the 
bariatric surgery outpatient clinic of our university’s teaching 
hospital. It was submitted for evaluation and was then approved 
by the local ethics review board (289.425). The laws and norms 
regarding studies on humans were followed, in accordance with 
resolution 196/96 of the National Health Council and all the par-
ticipants in the study signed an informed consent statement.
Sampling and participants
The power of the sample was calculated based on the global 
AQLQ(S) (Standardized Asthma Quality of Life Questionnaire) 
and a sample power of 88% was obtained.
The inclusion criteria were that the subjects needed to:
• present morbid obesity (BMI ≥ 40 kg/m2);
• be candidates for bariatric surgery;
• have a clinical diagnosis of asthma in accordance with the Global 
Initiative for Asthma consensus statement1 and/or antecedents 
of any episode of bronchospasm at any time during their lives 
and/or current or previous use of medication to treat asthma.
The exclusion criteria were the presence of:
• smoking habit;
• cognitive impairment that could impede performance of the 
clinical tests and completion of the questionnaire;
• respiratory diseases other than asthma;
• congestive heart failure or cardiovascular ischemic disease.
The recruitment period for the participants was from February 
2015 to April 2016.
Adult individuals were screened at the time of registration to 
enter the outpatient clinic and become candidates for bariatric 
surgery. On this occasion, they filled out a registration form that 
asked for information about the presence of asthma. Those who 
reported having asthma or experiencing episodes of broncho-
spasm without an ultimate diagnosis, and who fulfilled the other 
criteria, were then informed about the procedures of the study 
and were invited to take part in it. The procedures would involve 
clinical confirmation of the diagnosis of asthma by means of con-
sultations with a physiotherapist, evaluation with a pneumologist 
physician and performance of spirometry. 
Pulmonary function tests and asthma diagnosis
Asthma was investigated based on the symptoms that individu-
als reported having had over their whole lifetime, such as episodes 
of bronchospasm, breathlessness, sensation of chest tightness and 
coughing,1,6 or in situations in which individuals were routinely 
using medications for asthma, in accordance with the Global 
Initiative for Asthma consensus statement.1 Once diagnosed, these 
individuals would undergo pulmonary function tests to assess the 
severity of the disease. Other respiratory diseases were excluded 
based on anamnesis and pulmonary function test. 
Spirometry was performed at the Pulmonary Function 
Laboratory under supervision by a technical team and the norms 
of the American Thoracic Society (ATS) and European Respiratory 
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Society (ERS)7 were followed. To evaluate measurements of pulmo-
nary volumes and flows, two maneuvers were performed: slow vital 
capacity and forced vital capacity. The maneuvers were performed 
repeatedly until three acceptable curves were obtained, of which 
two needed to be reproducible. The total number of trials could 
not exceed eight. The subjects rested for 10 minutes before the test 
and received appropriate orientations during the test. 
The maneuvers were performed at two times: before and after using 
a bronchodilator (salbutamol, 200-400 µg) to observe the increase in 
the forced expiratory volume in the first second (FEV1) and/or the peak 
expiratory flow (PEF). Asthma is diagnosed when there is a 12% or 
200 ml increase in FEV1 and a 20% or 60 liter/min increase in PEF, in 
relation to the pre-bronchodilator values. The subjects were instructed 
to suspend their use of bronchodilator for 8-12 hours before the test.1,6
Evaluation procedures and outcome measurements
Antropometric data were collected and the quality of life was 
assessed follows.
The following anthropometric data were collected: weight, 
height and BMI. Weight was measured by means of a digital weigh-
ing machine (Filizola ID-1500, Brazil), with a capacity of 300 kg 
capacity and precision of 0.1 kg. Height was measured by means 
of a wall-mounted stadiometer, with a capacity of 2 meters and 
precision of 0.1 cm. Body mass index (BMI) was calculated by 
means of Quetelet’s formula,8 i.e. weight/(height2).
Quality of life was assessed by means of the Standardized Asthma 
Quality of Life Questionnaire (AQLQ(S)), which is a self-applicable 
questionnaire consisting of 32 questions that evaluate the last two 
weeks within four separate domains (impairment of activities, symp-
toms, emotions and environmental stimuli). It was developed by 
Juniper et al.9 and was validated and standardized by Juniper et al.10 
It has been translated into Portuguese for use in Brazil, as well as 
into more than 30 other languages. The Brazilian Portuguese version 
was validated and was considered to have good reproducibility and 
characteristics similar to those of the original instrument.11 Thus, it 
could be used for the population of the present study.
The questionnaire scores are calculated from the means of 
each domain; the scores range from 1 to 7. The higher the score 
is, the better the quality of life is. The questionnaire contains spe-
cific questions relating to asthma and respiratory symptoms that 
are triggered in specific activities and, therefore, assesses these 
conditions without connection with obesity.
Statistical analysis
The data were encoded for the SPSS 13.0 software and descrip-
tive analysis was performed. The individuals were divided into two 
groups based on the scores obtained from the questionnaire (bet-
ter or worse quality of life). The cutoff value for defining the groups 
was obtained through descriptive analysis on the overall AQLQ(S), 
which found a median score of 3.96 points. Thus, the cutoff value of 
4 was used. In addition, according to Juniper et al.,9 4.0 is an inter-
mediate score in the questionnaire and therefore separates between 
worse and better quality of life.
In this manner, the subjects were then divided between group 1 
(worse QOL; score < 4) and group 2 (better QOL; score ≥ 4). 
These groups were compared regarding their anthropometric data 
and pulmonary function results, by means of the Mann-Whitney 
test. The significance level used was 5% (P-value < 0.05).
RESULTS
During the study period, there were three inscription events to enlist 
candidates for bariatric surgery at our service. On the first occasion 
(March 2014), 1,782 individuals were registered and, of these, 82 (4.6%) 
were reported as asthmatic; on the second occasion (December 2014), 
1,781 were registered and, of these, 61 (3.42%) were reported as asth-
matic; and on the third occasion (November, 2015), 1,228 individuals 
were registered and, of these, 76 (6.18%) were reported as asthmatic. 
Hence, out of an overall population of 4,791 individuals with obesity, 
219 (5.57%) reported having asthma symptoms. Figure  1 shows a 
graphic representation of this phase of the recruitment. 
For patients to be called up to begin the preoperative program, 
the criteria used were their severity of obesity and comorbidities, 
their position on the waiting list and the availability of preoperative 
examinations and surgical vacancies. Up to the end of the study 
period, 91 asthmatic individuals were called up to enter the pro-
gram and, of these, 82 adequately filled out the proposed question-
naire. All the individuals in our sample who reported in this file 
that they had suggestive symptoms and who were called up for the 
program were confirmed as having a clinical diagnosis of asthma.
Anthropometric data were collected from these 82 individuals 
and are presented in Table 1. After analysis on the sample, they 
were stratified as having “better” or “worse” QOL, according to the 
scores obtained in the questionnaire. The features that significantly 
differed between the groups were height (P = 0.004) and pre-bron-
chodilator pulmonary function test values, which presented a sig-
nificant difference regarding forced expiratory flow (FEF) 25-75%, 
which was higher in the group with better QOL group (P = 0.043). 
Table 2 shows the characteristics of both groups.
Figure 1. Patient recruitment flow in the study.
1st inscription 
for bariatric 
surgery (n = 1782)
 2nd inscription 
for bariatric 
surgery (n = 1781)
3rd inscription 
for bariatric 
surgery (n = 1228)
Asthmatic (n = 82) Asthmatic (n = 61) Asthmatic (n = 76)
Called up (n = 91)
Filled out the 
questionnaire (n = 82)
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Table 1. Overall characteristics of the study population. Data expressed as means and standard deviations (SD), and as medians and quartiles
n Mean ± SD Median 1st quartile 3rd quartile
Anthropometry
Age (years) 81 39.24 ± 9.42 37.0 32.0 46.0
Weight (kg) 80 117.07 ± 18.62 115.3 103.9 125.8
Height (cm) 80 160.91 ± 6.00 161.5 157.0 165.0
BMI (kg/m2) 80 45.27 ± 6.79 44.3 41.35 48.5
Excess weight (kg) 80 58.48 ± 17.65 56.25 46.15 65.57
AQLQ(S)
Overall 82 3.87 ± 1.45 3.96 2.60 4.94
Limitation on activities 82 4.12 ± 1.38 4.13 2.79 5.36
Symptoms 82 3.89 ± 1.53 3.83 2.50 5.08
Emotions 82 3.71 ± 1.86 3.50 1.80 5.45
Environmental stimuli 82 3.30 ± 1.76 2.62 1.75 4.81
Pulmonary function
FVC (L) 73 2.85 ± 0.62 2.87 2.37 3.30
FEV1 (L) 73 2.24 ± 0.59 2.24 1.78 2.70
FEV1/FVC (%) 73 77.17 ± 12.46 79.70 72.90 84.65
PEF (L/s) 73 5.30 ± 1.44 5.36 4.40 6.11
FEF 25-75 (L/s) 73 2.29 ± 1.12 2.12 1.47 3.05
FEF75 (L/s) 63 4.59 ± 1.70 4.65 3.51 5.85
FEF50 (L/s) 63 2.97 ± 1.42 2.89 1.87 4.05
FEF25 (L/s) 63 0.99 ± 0.54 0.81 0.59 1.36
FIVC (L) 73 2.85 ± 0.62 2.87 2.39 3.21
PIF (L/s) 73 4.16 ± 1.36 4.05 3.07 5.14
BMI = body mass index; AQLQ(S) = Standardized Asthma Quality of Life Questionnaire; FVC = forced vital capacity; FEV1 = forced expiratory volume in 1
st second; 
PEF = peak expiratory flow; FEF = forced expiratory flow; FIVC = forced inspiratory vital capacity; PIF = peak inspiratory flow; L = liter.
Table 2. Comparison of the pre-bronchodilator pulmonary function tests between the “better” and “worse” quality of life (QOL) groups 
(cutoff value = 4)
Median (1st-3rd quartile)
P-value 
Worse QOL (n = 41) Better QOL (n = 41)
Anthropometry
Age (years) 37.0 (32.0-45.5) 37.0 (31.2-46.0) 0.951
Weight (kg) 112.6 (103.9-120.7) 118.4 (103.9-131.4) 0.130
Height (cm) 159.0 (154.2-163.7) 163.0 (158.2-166) 0.004*
BMI (kg/m2) 43.5 (40.4-49.2) 45.25 (41.6-47.8) 0.773
Excess weight (kg) 55.05 (45.0-63.8) 59.55 (46.6-71.1) 0.235
Pulmonary function 
FVC (L) 2.76 (2.31-3.16) 2.93 (2.54-3.38) 0.126
FEV1 (L) 2.13 (1.52-2.59) 2.35 (1.91-2.86) 0.060
FEV1/FVC (%) 77.55 (69.5-84.02) 82.10 (76.5-85.2) 0.103
PEF (L/s) 5.26 (3.98-6.11) 5.44 (4.49-6.11) 0.504
FEF 25-75 (L/s) 1.77 (1.11-2.87) 2.51 (1.74-3.35) 0.043*
FEF75 (L/s) 4.35 (2.70-5.85) 4.72 (3.98-5.69) 0.371
FEF50 (L/s) 2.62 (1.65-3.82) 3.50 (2.08-4.46) 0.105
FEF25 (L/s) 0.77 (0.45-1.28) 0.95 (0.61-1.36) 0.132
FIVC (L) 2.85 (2.19-3.13) 3.0 (2.55-3.38) 0.090
PIF (L/s) 4.06 (2.99-5.02) 4.01 (3.11-5.64) 0.982
*Statistically significant P value; BMI = body mass index; AQLQ(S) = Standardized Asthma Quality of Life Questionnaire; FVC = forced vital capacity; FEV1 = forced 
expiratory volume in 1st second; PEF = peak expiratory flow; FEF = forced expiratory flow; FIVC = forced inspiratory vital capacity; PIF =: peak inspiratory flow; L = liter.
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DISCUSSION
In a meta-analysis conducted by Beuther et al.,2 obese individuals 
presented higher risk of developing asthma than did lean subjects. 
The prevalence of asthma in the present study was 4.57% in a pop-
ulation of 4,791 individuals. This prevalence is low in comparison 
with what was found in the study by Melo et al.,12 which was 18.5% 
in a population of 363 obese individuals. However, in our study, 
asthma was reported in our subjects’ registration files for their entry 
to the preoperative program for bariatric surgery, i.e. before contact 
with the multiprofessional team or detailed clinical interview. 
It is known that asthma may be underdiagnosed in low-income 
obese populations for several reasons, such as poor access to infor-
mation or to specific healthcare services that provide diagnosis and 
management of asthma. Moreover, individuals may interpret their 
own episodes of wheezing as physical tiredness caused by obesity, 
which would remit without use of medications or medical evalu-
ation. In such situations, they might not provide this information 
at the time that the registration file is filled out. However, all the 
individuals in our sample who reported in this file that they had 
suggestive symptoms and who were called up for the program were 
confirmed as having a clinical diagnosis of asthma, determined 
through the reported clinical history.
All the individuals in this study present grade III obesity (BMI 
40-49.9 kg/m2), with a mean BMI of 45.27 ± 6.79 kg/m2. Grade III 
obesity causes severe changes to pulmonary function due to sev-
eral factors, such as fat deposition around the thorax and abdo-
men, which limits adequate movements of the thorax13 and changes 
pulmonary compliance.14,15 This leads to microatelectasis in the 
pulmonary inferior lobes16,17 and reduces functional capacity,13,18 
which compromises performance of simple daily activities, due 
to early tiredness. Furthermore, the low-grade systemic inflam-
matory state caused by fat tissue has the capacity to influence the 
lung parenchyma,19 thereby leading to episodes of bronchospasm.
Besides changes to pulmonary function, obesity may lead to 
physical limitations, postural changes and joint overload,20 which 
gives rise to joint pain and impairment of walking ability and 
daily activities. Such impairments, both pulmonary and physi-
cal, directly affect the QOL of these individuals, and weight loss 
is strongly recommended. Hence, the individuals called up for the 
study were instructed to begin preparations for the preoperative 
assessment for bariatric surgery, which favors a healthy lifestyle, 
especially regarding diet and physical activity.
The QOL data obtained demonstrated that the individu-
als scored in the medium band of the score scale from 1-7 
(median = 3.96 points) and, thus, presented moderately com-
promised QOL in all the domains evaluated. The domain 
with the best final score related to limitations on activities 
(median = 4.13 points) and the worst related to environmen-
tal stimuli (median = 2.62 points).
The domain with the best score (albeit still denoting moderate 
impairment), relating to limitations on activities, comprised questions 
on specific daily activities that may cause episodes of bronchospasm 
and breathlessness and the degree of limitation that these cause to the 
individual (such as walking, running, practicing exercises, working, 
socializing etc.). These were not necessarily physical limitations, but 
could also be limitations relating to fear of exposure to risky situations.
The worst-scoring domain related to environmental stimuli, which 
comprised specific questions on symptoms caused by smoke, dust, foul 
weather, pollution and perfume fragrances. External environmental 
stimuli may potentiate systemic pulmonary inflammation, thus lead-
ing to hyperresponsivity of the airways and episodes of bronchospasm.
When the individuals were stratified into two groups according 
to their asthma-related QOL, it was observed that the individuals 
with better QOL also presented significantly higher FEF 25-75% 
(P = 0.043). FEF represents the mean forced expiratory flow in the 
intermediate band of forced vital capacity (FVC), i.e. between 25 
and 75% of the FVC curve.21 FEF 25-75% depends on the elastic 
retraction force of the lungs, the permeability of the small airways 
and the muscle strength. Its measurement provides information 
on the permeability of the small airways and is unrelated to the 
patient’s collaboration.22 Thus, all of the mechanical and inflam-
matory changes present in the lungs of morbidly obese individu-
als may lead to changes in the permeability of low-caliber airways, 
which is mirrored in measurements of FEF 25-75%.12 
Although the FEV1/FVC% ratio is the measurement that best rep-
resents obstructive disorders,21 it was normal in our study, albeit at the 
lower limit. According to Pereira,21 patients with established chronic 
obstructive pulmonary disease (COPD) tend to show much more sur-
prising changes in FEF 25-75% than in the FEV1/FVC% ratio. However, 
because of the correlation between FEF 25-75% and FEV1/FVC%, the 
FEF 25-75% measurement becomes redundant when the FEV1/FVC% 
ratio is abnormal. Therefore, if the FEV1/FVC ratio is borderline, a 
reduction in FEF 25-75% or other terminal flows indicates airflow 
obstruction in individuals with symptomatic respiratory disorders.
According to Lebecque et al.,22 for mild asthma, FEF 25-75% 
appeared to be more sensitive than the FEV1/FVC ratio for indi-
cating the presence of small-caliber airway obstruction.
In the present study, although no relationship was found for 
other spirometric variables, it could be seen that the values of 
FEV1, FEF and FEF 25% also were below the normal range when 
the non-stratified sample was analyzed, this finding is expected 
in asthmatic individuals.21,23 
Some studies in which pulmonary function tests were performed 
on obese individuals without pulmonary abnormalities showed sig-
nificant reductions in functional residual capacity (FRC)13,24 and 
expiratory reserve volume (ERV)13,25,26 that were attributable to the 
mechanical changes that fat tissue causes to the thorax. Nonetheless, 
the changes in FEF 25-75% was attributed by Sood13 to inflammatory 
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changes that occurred in the lungs of obese individuals, thereby lead-
ing to premature closure of the small airways during forced expi-
ration. This might explain the relationship between the severity of 
asthma and the observed values of FEF 25-75%. Such changes in the 
small airways may contribute towards situations in which low effort 
or low environmental stimuli provoke episodes of bronchospasm and 
breathlessness, thus compromising the QOL of these individuals.
There is recent evidence highlighting the burdens on QOL 
caused by certain situations, such as asthma. In a study that used the 
same QOL evaluation questionnaire as in the present study, Rocha27 
observed that asthma had a significant impact on QOL even when 
partly controlled. Furthermore, in a review of literature conducted 
by Araújo et al.,28 it was concluded that the QOL and sleep quality 
of asthmatic individuals were compromised. On the other hand, in 
a study by Pereira et al.29 that used the Saint George’s Respiratory 
Questionnaire (SGRQ) to assess the QOL of individuals with asthma 
and chronic obstructive pulmonary disease (COPD), it was observed 
that, when the disease was classified as mild to moderate and was 
adequately treated, there was no impairment of QOL.
In studies that evaluated the impact of obesity on QOL, there 
was evidence that obesity led to impairment of QOL. Weight loss 
might improve the overall QOL within this group.30-32
Hence, since impairments of QOL occur in both diseases, an asso-
ciation between them would be expected to cause even more dam-
age. This explains the importance of measuring QOL in these cases, 
in such a way that therapeutic strategies and goals can be designed.
Since we identified that worse QOL in the present study was 
related to greater impairment of pulmonary function, it is possible for 
the attending physician to identify individuals with disease of greater 
severity by means of a simple questionnaire that may be self-applicable. 
This would reduce the need for additional pulmonary function tests 
and, thus, minimize the cost of therapy for these individuals, since 
improvement of the symptoms and QOL should be the ultimate goal.
Therefore, the possibility of classifying the QOL of asthmatic 
obese individuals by means of a questionnaire may provide attend-
ing physicians with significant information on the degree of impair-
ment of pulmonary function in these individuals and make it 
possible to define strategies for better and individualized therapy.
Limitations
Although the Brazilian Portuguese version of the questionnaire has 
many properties similar to the original instrument, and is a valid 
instrument for this population according to the authors who validated 
it, these authors mentioned in their validation study that hardly any 
study can claim to provide full validation. Therefore, studies that vali-
date the questionnaire more appropriately would be required, and this 
might constitute a form of bias for research that uses the instrument. 
Nonetheless, the original questionnaire was translated into Brazilian 
Portuguese in accordance the internationally accepted methodology.
CONCLUSION
The prevalence of asthma in the study population was 4.57%. The QOL 
of individuals with asthma and obesity was impaired. The worst QOL 
domain related to environmental stimuli and the best QOL domain 
related to the limitations of the activities. Worse QOL correlated with 
lower values for FEF 25-75% in the pulmonary function test.
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